Strategies to Reduce Bleeding Risk in Acute Coronary Syndromes and Percutaneous Coronary Intervention: New and Emerging Pharmacotherapeutic Considerations-Reference-Cited by-同舟云学术

Strategies to Reduce Bleeding Risk in Acute Coronary Syndromes and Percutaneous Coronary Intervention: New and Emerging Pharmacotherapeutic Considerations

Published:2014-06-05 Issue:9 Volume:34 Page:973-990
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Coons James C.¹,Miller Taylor²

Affiliation:

1. University of Pittsburgh School of Pharmacy; Pittsburgh Pennsylvania

2. Department of Pharmacy; UPMC-Presbyterian Hospital; Pittsburgh Pennsylvania

Publisher

Wiley

Subject

Pharmacology (medical)

Reference75 articles.

1. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes;Rao;Eur Heart J,2007

2. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation;Hansen;Arch Intern Med,2010

3. Standardized bleeding definitions for cardiovascular clinical trials;Mehran;Circulation,2011

4. Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention;Marso;JAMA,2010

5. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention;Chhatriwalla;JAMA,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy;Biomedicine & Pharmacotherapy;2016-10

2. Is platelet transfusion the solution to reverse platelet inhibition in patients on triple antiplatelet therapy?;Thrombosis Research;2015-12